Related Experiment Videos
Dramatic post-cardiotomy outcome, due to severe anaphylactic reaction to protamine
A Panos1, X Orrit, C Chevalley
1Clinic for cardio-vascular surgery, Department of Surgery, University Hospital of Geneva, 24, rue Micheli-du-Crest, 1211 Geneva 14, Switzerland. aristotepanos@yahoo.com
Summary
Anaphylactic reactions to protamine sulfate during cardiac surgery are rare but can be lethal. This case highlights the importance of recognizing and managing these severe immunologic reactions in non-diabetic patients.
Area of Science:
- Cardiovascular Surgery
- Immunology
- Anesthesiology
Background:
- Protamine sulfate is used to reverse heparin anticoagulation after cardiopulmonary bypass.
- Immunologic reactions to protamine are considered rare, with limited data on their frequency and outcomes.
- Cardiac surgery patients may be at risk for protamine-induced adverse events.
Observation:
- A non-diabetic patient experienced a lethal anaphylactic reaction to protamine sulfate.
- The reaction occurred after an uneventful ascending aorta replacement surgery.
- This case underscores the potential severity of protamine hypersensitivity.
Findings:
- Lethal anaphylaxis to protamine sulfate is a rare but critical adverse event.
- The immunologic mechanism of protamine reactions involves hypersensitivity.
- Management strategies for protamine reactions require careful consideration.
Implications:
- Increased awareness of protamine hypersensitivity is crucial for cardiac surgeons and anesthesiologists.
- Prompt recognition and management can potentially mitigate severe outcomes.
- Further research into the mechanisms and prevention of protamine reactions is warranted.